Puissance Life Science Opportunities Fund VI insider trades: Bellerophon Therapeutics (BLPH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Puissance Life Science Opportunities Fund VI reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 13, 2023 | BLPH | ↓ Sell | 1,076,841 | $0.10 | $112K | Direct | Oct 16, 2023 (3d) |
| Jun 7, 2023 | BLPH | ↓ Sell | 134,421 | $0.83 | $112K | Direct | Jun 7, 2023 (0d) |
| May 18, 2023 | BLPH | ↓ Sell | 560,000 | $9.46 | $5.3M | Direct | May 19, 2023 (1d) |
| Nov 29, 2018 | TCON | ↓ Sell | 4,326 | $1.21 | $5K | By funds | Dec 3, 2018 (4d) |
| Nov 29, 2018 | TCON | ↑ Buy | 4,326 | $1.13 | $5K | By funds | Dec 3, 2018 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Puissance Life Science Opportunities Fund VI's insider trades
Puissance Life Science Opportunities Fund VI is a 10% owner of Bellerophon Therapeutics (BLPH). Since Nov 29, 2018, it has reported 1 open-market purchase worth $5K and 4 sales worth $5.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.